Demos
TrialMind product demos
One-minute overviews for each team, and recorded walkthroughs of TrialMind on real studies.
New walkthroughs
One study, two steps: from a trial landscape to a review question, then from the review question to source evidence.
From a trial landscape to a review questionRuntime 2:09
Start from osimertinib, search its 282 trials, map the non-small cell lung cancer landscape, check conference intelligence, and land on the FLAURA2 trial.
FLAURA2 systematic literature reviewRuntime 2:04
A review question on osimertinib with chemotherapy, taken through search, screening, extraction with highlighted source text, and a cited draft.
One-minute overviews
What TrialMind does for each team, shown on real outputs.
Product overviewRuntime 0:59
From a research question to an analysis plan, code that runs in your environment, and results traced back to the data.
Real-world evidence teamsRuntime 0:52
A HER2-altered lung cancer cohort and sepsis treatment patterns, with the code behind every step.
Biometrics teamsRuntime 0:55
Mapping to SDTM, generated code, Pinnacle 21 checks and a digital twin trial design.
Clinical operations teamsRuntime 0:38
Eligibility criteria turned into screening rules, with the reason for every exclusion.
Competitive intelligence teamsRuntime 0:38
A KRAS G12C trial landscape and conference coverage, with a link to every source.
Health economics and market accessRuntime 0:45
A systematic literature review of GLP-1 drugs, from search to a cited draft.
Research institutionsRuntime 0:34
A reproducible atrial fibrillation study on MIMIC, from analysis plan to patient flow diagram.
TrialPanoramaRuntime 1:18
Semaglutide, tirzepatide and SURMOUNT-5: trials linked to drugs, results, adverse events and publications.
TrialPanorama knowledge base
About TrialPanoramaFind investigators for your next studyRuntime 1:34
Rank the investigators linked to the most obesity trials, open one investigator's trial history, and follow it to the registry record.
From the Tukysa approval to the liver safety dataRuntime 2:02
Start from the FDA approval of tucatinib (Tukysa) and trace it to the liver safety results of the HER2CLIMB-05 trial.
From ALS news to the evidence behind a drug programRuntime 1:29
Start from a news item about tofersen for ALS and follow it to the trials, approvals, and publications behind the program.
Ask, check, and save obesity trial evidenceRuntime 1:30
Ask about survodutide's SYNCHRONIZE-2 trial, check the answer against the source records, and save the evidence.
Biostatistics & Trial Design
View the solutionAnalysis dataset (ADaM) creationRuntime 2:14
CDISC Analysis Data Model (ADaM) tables derived from Study Data Tabulation Model (SDTM) domains, with the analysis plan recorded alongside the output.
Real-World Evidence
View the solutionFrom cohort definition to survival analysisRuntime 1:10
A recorded walkthrough of TrialMind on real data, from defining a cohort to a survival analysis.
Cohort extraction from real-world dataRuntime 2:20
TrialMind writes the code to extract an eligible cohort from real-world data, then analyzes it.
Trial feasibility analysisRuntime 0:41
A feasibility question asked in plain language, answered with charts, without a separate data engineering step.
Lung cancer EGFR inhibitor feasibility and resistanceRuntime 1:47
Feasibility and resistance analysis for EGFR tyrosine kinase inhibitor (TKI) therapies in non-small cell lung cancer (NSCLC), on real-world data.
KRAS G12C patient journeysRuntime 1:54
Treatment journeys of patients with KRAS G12C-mutant cancer, shown as summary dashboards and Sankey flow diagrams.
Health Economics & Market Access
View the solutionSystematic literature reviewRuntime 9:26
Search, screening, and extraction through to evidence synthesis, with decisions recorded.
Competitive & Portfolio Intelligence
View the solutionExplore a PTRS estimate for Himalayas-1Runtime 1:32
A Bayesian estimate of rinzimetostat's probability of technical and regulatory success (PTRS) in the Phase 3 Himalayas-1 trial: adjust the priors, read the summary, and see which assumption moves the estimate most.
Probability of success predictionRuntime 1:36
Deep research across competing trials, literature, and drug evidence to assess regulatory success.
Clinical Development & Operations
View the solutionPatient-to-trial matchingRuntime 1:56
Matching patients to actively recruiting trials against protocol eligibility criteria.
Book a demo on your own data
We can run TrialMind on a question from your own work in a live session.